Skip to main content

Coca-Cola Consolidated Recall: Product labeled Dr. Pepper may instead contain Diet Dr. Pepper (containing undeclared Aspartame as a sweetener).

United States

TerminatedClass III

Company
Coca-Cola Consolidated
Product
Dr. Pepper, 2 Liters (2.1 qt) plastic bottles, Bottled under…
Recall date
January 5, 2017
Terminated
January 30, 2017
Source
FDA

Reason for recall

Product labeled Dr. Pepper may instead contain Diet Dr. Pepper (containing undeclared Aspartame as a sweetener).

  1. - Recall initiated
  2. - Reported by source
  3. - Recall terminated
Recalled products
Product description UPC Quantity Lot / code information
Dr. Pepper, 2 Liters (2.1 qt) plastic bottles, Bottled under the authority of Dr. Pepper Company, 5301 Legacy Drive, Plano, TX 75024. Not published in this source record 297 cases (8 bottles/case) Date Code MAR2717syf

Distribution

  • NC

Official source record

Agency
FDA
Dataset
FDA Food Enforcement (Recalls)
Recall number
F-1344-2017
Event ID
76271
Status
Terminated
Classification
Class III
Company
Coca-Cola Consolidated
Product description
Dr. Pepper, 2 Liters (2.1 qt) plastic bottles, Bottled under the authority of Dr. Pepper Company, 5301 Legacy Drive, Plano, TX 75024.
Quantity
297 cases (8 bottles/case)
Reason
Product labeled Dr. Pepper may instead contain Diet Dr. Pepper (containing undeclared Aspartame as a sweetener).
Recall initiation date
January 5, 2017
Report date
February 1, 2017
Classification date
Not published in this source record
Termination date
January 30, 2017
Distribution pattern
NC
UPC, lot, and code information
Date Code MAR2717syf
Voluntary or mandated
Voluntary: Firm initiated
Initial notification method
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Source last updated
Not tracked separately from the Public Health Trace retrieval date below
Public Health Trace retrieval date

Responsible company: Coca-Cola Consolidated

Distribution map

A map highlighting the states named in the source's distribution description.

Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.

Distribution map
State Distributed
North Carolina 1

States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.

Where this information comes from

View FDA enforcement record -- the specific openFDA record this summary was built from.

No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Technical source data

View raw source data -- the machine-readable record this page's information was built from.

Retrieved by Public Health Trace:

Frequently asked questions

What does a Class III mean?

A situation in which use of or exposure to a product is not likely to cause adverse health consequences.

Is this recall still active?

According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this product?

Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.

Where can I find more official information?

The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.